Screener
Haemonetics HAE Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
| Line item | Three Months Ended / June 27, 2026 | Three Months Ended / June 28, 2025 |
|---|---|---|
| Change in prepaid income taxes | 6,101 | 3,346 |
| Change in other assets and other liabilities | (12,783) | (17,785) |
| Change in accounts payable and accrued expenses | (12,615) | (47,896) |
| Net cash provided by operating activities | 52,323 | 17,395 |
| Cash Flows from Investing Activities: | ||
| Capital expenditures | (7,906) | (3,754) |
| Non-cash transfers from inventory to property, plant and equipment for Haemonetics equipment | (5,565) | (11,460) |
| Proceeds from sale of property, plant and equipment | 237 | 297 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Haemonetics's operating cash flow?
- Haemonetics (HAE) reported operating cash flow of $52.32M in Q2 2026.
- How has Haemonetics's operating cash flow changed year-over-year?
- Haemonetics's operating cash flow increased by 200.8% year-over-year, from $17.4M to $52.32M.
- What is the long-term trend for Haemonetics's operating cash flow?
- Over 4 years (2022 to 2026), Haemonetics's operating cash flow has grown at a 14.2% compound annual growth rate (CAGR), from $172.26M to $293.22M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about Haemonetics's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude